Key points are not available for this paper at this time.
The chemokine CCL22 is recognized for recruiting immunosuppressive regulatory T-cells (Treg) that contribute to disease progression in various tumor entities helping them to evade the host immune response. Our study aims to identify the expressing cell types and to evaluate the prognostic significance of CCL22 secretion and its association with Treg invasion in endometrial cancer (EC), an immunogenic cancer.
Building similarity graph...
Analyzing shared references across papers
Loading...
M Mannewitz
Thomas Kolben
Carolin Perleberg
Translational Oncology
Ludwig-Maximilians-Universität München
Technical University of Munich
LMU Klinikum
Building similarity graph...
Analyzing shared references across papers
Loading...
Mannewitz et al. (Tue,) studied this question.
www.synapsesocial.com/papers/68e597e1b6db643587532aa2 — DOI: https://doi.org/10.1016/j.tranon.2024.102116